Format

Send to

Choose Destination
Blood. 2018 Dec 6;132(23):2425-2427. doi: 10.1182/blood-2018-10-879668.

CiTE antibody for AML.

Author information

1
Washington University in St. Louis.

Conflict of interest statement

Conflict-of-interest disclosure: J.F.D. receives research funding from Amphivena Therapeutics, MacroGenics, and Novimmune; serves as a consultant for Amphivena Therapeutics, Celgene, Incyte, Karyopharm Therapeutics, RiverVest Venture Partners, and Tioma Therapeutics; is an Advisory Board Member for Cellworks Group and RiverVest Venture Partners; and has equity ownership in Magenta Therapeutics and WUGEN. M.P.R. receives research funding from Amphivena Therapeutics and serves as a consultant for RiverVest Venture Partners.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center